Mr. Chair, I think it's really important that this committee focus on the science. They're either safe or they're not. If they're safe, this committee shouldn't be making moral judgments on what is appropriate or inappropriate.
I would like to say some things for the record. Silicone-gel-filled breast implants were voluntarily withdrawn from the Canadian market in January 1992 to allow Health Canada time to review new evidence of the safety and effectiveness of these implants.
The moratorium was lifted in January 1993, when manufacturers were informed that they would need to reapply for market authorizations and provide additional clinical evidence of the safety and effectiveness.
Health Canada is nearing the end of an extensive, thorough, and lengthy review of several licence applications for silicone gel breast implants. The results of this review will have an impact on the need for special access authorizations of these medical devices.
The requirements of the medical devices special access program are clearly stated in part 2 of the medical device regulations. During the review of special access authorization requests, Health Canada reviews the risks and benefits as determined by health care professionals for individual patients.
Health Canada cannot legally refuse a licence or special access authorization to a medical device that meets the regulatory requirements set out for its sale and importation in the Food and Drugs Act and in the medical device regulations. If a silicone-gel-filled breast implant is safe and effective for use in a cancer survivor, it is equally safe and effective for the same indicators in a person seeking augmentation or replacement of an existing device.
In summary, it is not Health Canada's role to determine the appropriateness of specific treatment for specific patients; these decisions are made by the treating physicians in consultation with their patients.
If we can make an amendment that would agree with that principle--that it's a relationship between the patient and the physician--I think we could support it, but it's not the role of this committee to go beyond that.